Programmable mRNA antibiotics show potential to combat antibiotic-resistant bacteria

By The Science Advisory Board staff writers

June 29, 2022 -- Antibiotic-resistant bacterial strains are growing worldwide, with traditional antibiotics increasingly failing. However, programmable mRNA could be the solution to the problem, according to researchers.

"If we don't want to watch antibiotic-resistant microbes to thwart the successes of modern medicine, we need novel tools that facilitate targeted treatment of pathogens," said Jörg Vogel, managing director of the Helmholtz Institute for RNA-based Infection Research and director of the Institute for Molecular Infection Biology at Julius Maximilian University.

During the COVID-19 pandemic, mRNA vaccines were quickly brought to market with the ability to teach the body's cells how to make a protein triggering an immune response. Now, scientists want to leverage RNA-based medicine for the development of a new type of antibiotic that can be used to treat bacterial infections.

A study, in the current issue of Nucleic Acids Research, showed that mRNA-based antibiotics are in principle suitable for combating uropathogenic strains of Escherichia coli. Nonetheless, several important questions still need to be addressed before using this approach in clinics.

Bioengineered peptide combats antibiotic-resistant bacteria
Researchers have engineered a bioinspired molecule that was highly effective in clearing infections caused by antibiotic-resistant bacteria strains in...
New sensor-based test could lead to fast, cheap antibiotic susceptibility testing
Scientists have developed a new method for monitoring bacterial responses to antibiotics that could enable personalized antibiotic therapies. The test...
Nanoparticles may offer new way to tackle antibiotic-resistant bacteria
A team of researchers has developed nanoparticles that use a completely different mode of action from conventional antibiotics. These inorganic nanoparticles...

Copyright © 2022 scienceboard.net


Conferences
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter